Article
Surgery
Shuangling Luo, Xingwei Zhang, Yujie Hou, Huanxin Hu, Jianghui Dong, Liping Wang, Liang Kang
Summary: The study demonstrates that transanal and transabdominal combined endoscopic resection for rectal anastomotic stenosis and anal reconstruction is clinically effective, with high safety, minimal intraoperative blood loss, shorter operation time, and good postoperative recovery.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2021)
Article
Surgery
Sapho Xenia Roodbeen, Antonino Spinelli, Willem A. Bemelman, Francesca Di Candido, Maylis Cardepont, Quentin Denost, Andre D'Hoore, Bert Houben, Joep J. Knol, Beatriz Martin-Perez, Eric Rullier, Dana Sands, Ilana Setton, Katrien Van de Steen, Pieter J. Tanis, Steven D. Wexner, Roel Hompes, Albert M. Wolthuis
Summary: This study aimed to determine the local recurrence (LR) rate and patterns after transanal total mesorectal excision (TaTME) for rectal cancer. The results showed good locoregional control after TaTME in selected cases from tertiary referral centers and did not indicate an inherent oncological risk of the surgical technique.
Article
Surgery
Han Beol Jang, Sang-Bum Kang, Hyein Lee, Byung Jo Choi, Sang Chul Lee
Summary: The study found no significant differences in the occurrence of anastomotic leakage and chronic presacral sinus between Transanal Total Mesorectal Excision (taTME) and Laparoscopic TME (lapTME) in rectal cancer patients. Almost one-third of anastomotic leakages developed into chronic presacral sinus.
ASIAN JOURNAL OF SURGERY
(2022)
Article
Gastroenterology & Hepatology
Liang Kang, Ziwei Zeng, Shuangling Luo, Hong Zhang, Quan Wang, Mingyang Ren, Miao Wu, Weidong Tong, Qing Xu, Yi Xiao, Aiwen Wu, Yuan-Guang Chen, Bo Feng, Zhanlong Shen, Liang Huang, Xingwei Zhang, Minhua Zheng, Jian-Ping Wang
Summary: The TaLaR trial aims to compare short-term and long-term outcomes between taTME and lapTME for rectal cancer patients. The primary endpoints include the 3-year disease-free survival rate and the 5-year overall survival rate, while secondary endpoints focus on specimen quality, perioperative results, pelvic and anal function, and quality of life.
GASTROENTEROLOGY REPORT
(2021)
Article
Oncology
Severin Gloor, Gioia Pozza, Rebekka Troller, Markus Wehrli, Michel Adamina
Summary: A study of 165 patients with distal rectal cancer who underwent taTME found that this procedure is a viable alternative to conventional TME, with high surgical quality and favorable outcomes.
Review
Health Care Sciences & Services
Fabio Rondelli, Alessandro Sanguinetti, Andrea Polistena, Stefano Avenia, Claudio Marcacci, Graziano Ceccarelli, Walter Bugiantella, Michele De Rosa
Summary: Total mesorectal excision is the gold standard technique for rectal cancer surgery, while the transanal approach to the mesorectum was introduced to overcome technical difficulties related to distal rectal dissection. Research shows that this approach is most beneficial for patients with mid-low rectal cancer and is safe and feasible, with oncological and functional outcomes comparable to traditional approaches.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Gastroenterology & Hepatology
L. Sanchon, M. Bardaji, M. Labro, J. Curto, C. Soto, A. Puig, J. C. Pastor, C. Gomez, A. Osorio, C. Guariglia, S. Pardo, C. Vidal, P. Collera
Summary: This study evaluated the early experience with transanal total mesorectal excision (TaTME) in the surgical treatment of rectal neoplasia. The results showed that TaTME had comparable surgical, anatomopathological, and oncological outcomes at 3 years (medium-term) to laparoscopic and open approaches. However, better monitoring is required for long-term functional and quality of life outcomes.
TECHNIQUES IN COLOPROCTOLOGY
(2023)
Review
Oncology
Du Yong Gang, Lin Dong, Zhang DeChun, Zhang Yichi, Lu Ya
Summary: This study comprehensively and systematically evaluated the safety and efficacy of MiTME and TaTME in the treatment of mid to low-rectal cancer through meta-analysis. There is no difference between the two except for patients with MiTME who have a lower anastomotic leakage rate, which provides some evidence-based reference for clinical practice. Of course, in the future, more scientific and rigorous conclusions need to be drawn from multi-center RCT research.
FRONTIERS IN ONCOLOGY
(2023)
Article
Gastroenterology & Hepatology
Paula Manchon-Walsh, F. Borja de Lacy, Miguel Pera, Eloy Espin-Basany, Eduardo M. Targarona, Sebastiano Biondo, Luisa Aliste Sanchez, Natalia Pallares, Cristian Tebe, Francesco Pata, Antonio M. Lacy, Alex Guarga, Josep M. Borras
Summary: This study compared the effects of transanal versus anterior total mesorectal excision for rectal cancer, showing no significant differences in local recurrence and disease-free survival at 2 years post-operation.
DISEASES OF THE COLON & RECTUM
(2022)
Article
Gastroenterology & Hepatology
W. Lossius, T. Stornes, T. E. Bernsyein, A. Wibe
Summary: The study demonstrates that TAMIS surgery is associated with a low risk of complications and low recurrence rate in rectal neoplasms. In cases of adenocarcinoma, R0 cTME surgery is feasible for patients with high risk T1 and T2 tumors.
TECHNIQUES IN COLOPROCTOLOGY
(2022)
Article
Surgery
Carolina Gonzalez-Abos, F. Borja de Lacy, Yoelimar Guzman, Sara T. Nogueira, Ana Otero-Pineiro, Raul Almenara, Antonio M. Lacy
Summary: This study aimed to analyze the pattern of local recurrence for patients treated with TaTME in a tertiary referral center. The results showed that TaTME provided satisfactory local recurrence outcomes, with the most common patterns of failure occurring in the central pelvis.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2021)
Article
Surgery
Toshiyuki Adachi, Daichi Kitaguchi, Koichi Teramura, Hiro Hasegawa, Koji Ikeda, Yuichiro Tsukada, Yuji Nishizawa, Takeshi Sasaki, Masaaki Ito
Summary: This retrospective study compared the short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers. The transanal group had significantly shorter operative times, lower positive circumferential resection margins rates, and lower incidence of grade III and IV complications compared to the laparoscopic group. This demonstrates the safety and usefulness of transanal total mesorectal excision for middle and low rectal cancers.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Surgery
Jung Kyong Shin, Hee Cheol Kim, Seong Hyeon Yun, Yoon Ah Park, Yong Beom Cho, Jung Wook Huh, Woo Yong Lee
Summary: Both transanal total mesorectal excision (taTME) and robotic total mesorectal excision (R-TME) have similar short-term outcomes for patients with rectal cancer after undergoing neoadjuvant chemoradiation. High quality total mesorectal excision can be equally achieved with both transanal and robotic approaches.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2021)
Article
Surgery
Jingqing Ren, Shaojie Liu, Huixing Luo, Bailin Wang, Fan Wu
Summary: There was no significant difference in short-term efficacy between TaTME and LaTME for low rectal cancer, but TaTME had a longer operation time and a greater circumferential resection margin distance.
ASIAN JOURNAL OF SURGERY
(2021)
Article
Surgery
Ziwei Zeng, Zhihang Liu, Shuangling Luo, Zhenxing Liang, Liang Huang, Lei Ruan, Junji Chen, Haiqing Jie, Wenfeng Liang, Huashan Liu, Liang Kang
Summary: There were no significant differences in the 3-year local recurrence rate between the taTME and laTME groups. Additionally, the disease-free survival and overall survival rates within 3 years after surgery were also similar between the two groups.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2022)
